NAVAMEDIC ASA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34.5 NOK | 0.00% |
|
+1.47% | -5.99% |
| 05-06 | Navamedic Rolls Out Erectile Dysfunction Drug in Sweden | MT |
| 04-30 | Navamedic ASA Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NAVAMEDIC ASA | Other Pharmaceuticals | 0.00% | +1.47% | -5.99% | -8.49% | +85.48% | 57.56M |  |  |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- NAVA Stock
- Charts Navamedic ASA
- Comparison Chart
